Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
Clinical trial NCT02302469 · COMPLETED
Trial details
- NCT number
- NCT02302469
- Sponsor
- University Hospital, Lille
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.